Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Antiviral Activity of TPV in Hepatitis C or Hepatitis B HIV Coinfected Patients - TDM Randomised Pilot Evaluation

NCT00447902 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT00447902
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00447902 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Antiviral Activity of TPV in Hepatitis C or Hepatitis B HIV Coinfected Patients - TDM Randomised Pilot Evaluation
Lead sponsor
Boehringer Ingelheim
Phase
Phase 3
Overall status
Terminated
Start date
March 31, 2007
Completion date
Not reported
Enrollment
11 (actual)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections